Related Experiment Video
Updated: May 5, 2026

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
Published on: March 25, 2019
Structural basis for molecular recognition of folic acid by folate receptors
Chen Chen1, Jiyuan Ke, X Edward Zhou
1Program for Structural Biology and Drug Discovery, Van Andel Research Institute, 333 Bostwick Avenue North East, Grand Rapids, Michigan 49503, USA.
Abstract:
Folate receptors (FRα, FRβ and FRγ) are cysteine-rich cell-surface glycoproteins that bind folate with high affinity to mediate cellular uptake of folate. Although expressed at very low levels in most tissues, folate receptors, especially FRα, are expressed at high levels in numerous cancers to meet the folate demand of rapidly dividing cells under low folate conditions. The folate dependency of many tumours has been therapeutically and diagnostically exploited by administration of anti-FRα antibodies, high-affinity antifolates, folate-based imaging agents and folate-conjugated drugs and toxins. To understand how folate binds its receptors, we determined the crystal structure of human FRα in complex with folic acid at 2.8 Å resolution. FRα has a globular structure stabilized by eight disulphide bonds and contains a deep open folate-binding pocket comprised of residues that are conserved in all receptor subtypes. The folate pteroate moiety is buried inside the receptor, whereas its glutamate moiety is solvent-exposed and sticks out of the pocket entrance, allowing it to be conjugated to drugs without adversely affecting FRα binding. The extensive interactions between the receptor and ligand readily explain the high folate-binding affinity of folate receptors and provide a template for designing more specific drugs targeting the folate receptor system.
Insights
Researchers determined the crystal structure of the folate receptor alpha (FRα) bound to folic acid. This structure reveals how FRα binds folate, offering a template for developing targeted cancer therapies.
Area of Science:
- Biochemistry
- Structural Biology
- Oncology
Background:
- Folate receptors (FRα, FRβ, FRγ) are cell-surface glycoproteins crucial for folate uptake.
- Elevated FRα expression in many cancers drives tumor growth, making it a therapeutic target.
Purpose of the Study:
- To elucidate the structural basis of folate binding to folate receptor alpha (FRα).
- To provide a structural template for designing novel FRα-targeted cancer drugs.
Main Methods:
- Determined the crystal structure of human FRα in complex with folic acid at 2.8 Å resolution.
Main Results:
- FRα possesses a globular structure with eight disulfide bonds and a deep, conserved folate-binding pocket.
- The pteroate group of folic acid is buried, while the glutamate group is exposed, enabling drug conjugation.
- Extensive receptor-ligand interactions explain high folate-binding affinity.
Conclusions:
- The determined FRα-folic acid structure provides critical insights into folate binding.
- This structural information can guide the development of more specific and effective folate receptor-targeted therapeutics.
More Related Videos
Related Concept Videos
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Ligand Binding and Linkage
Association Areas of the Cortex
Prefrontal Association Area: This area is located in the frontal lobe and is involved in planning, decision-making, and moderating social behavior. It connects with primary motor areas,...

